Techno Medical PCLBKK:TM-R 74 Return-on-Tangible-Equity is 7.51% as of Mar. 2026, which is 8% below its 10-year median of 8.12. GuruFocus rates BKK:TM-R with a GF Score™ of 74/100 and a GF Value™ of ฿3.03. The stock has 6 warning signs investors should review. Among 113 Medical Distribution companies, Techno Medical PCL ranks worse than 60.18% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Techno Medical PCL's annualized net income for the quarter that ended in Mar. 2026 was ฿31.2 Mil. Techno Medical PCL's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ฿415.3 Mil. Therefore, Techno Medical PCL's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 7.51%.
The historical rank and industry rank for Techno Medical PCL's Return-on-Tangible-Equity or its related term are showing as below:
BKK:TM-R'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -5.52 Med: 8.12 Max: 14.24
Current: 7.14
During the past 11 years, Techno Medical PCL's highest Return-on-Tangible-Equity was 14.24%. The lowest was -5.52%. And the median was 8.12%.
BKK:TM-R's Return-on-Tangible-Equity is ranked worse than 60.18% of 113
companies
in the Medical Distribution industry
Industry Median: 9.07
vs BKK:TM-R: 7.14
Techno Medical PCL (BKK:TM-R) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Techno Medical PCL Return-on-Tangible-Equity Related Terms
Techno Medical PCL Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Techno Medical PCL's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medical PCL Return-on-Tangible-Equity Chart
BKK:TM-R vs MCK, COR, CAH: Return-on-Tangible-Equity Comparison
For the Medical Distribution subindustry, Techno Medical PCL's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medical PCL Return-on-Tangible-Equity vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Techno Medical PCL's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Techno Medical PCL's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 7.51% mean?
Techno Medical PCL (BKK:TM-R) has a Return-on-Tangible-Equity of 7.51% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Techno Medical PCL and its competitors. This is near median its historical median of 8.12. According to the industry distribution chart, Techno Medical PCL ranks #68 out of 113 companies in the Medical Distribution industry, placing it in the top 60.2%.
Is Techno Medical PCL's Return-on-Tangible-Equity too high?
Techno Medical PCL's current Return-on-Tangible-Equity of 7.51% is near median its 10-year median of 8.12. The Medical Distribution industry median Return-on-Tangible-Equity is 9.07. Techno Medical PCL's value of 7.51% is 17.2% below this industry median. Based on the distribution chart, Techno Medical PCL ranks #68 out of 113 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Techno Medical PCL has a GF Score™ of 74/100, reflecting its overall financial health beyond just this single metric.
How does Techno Medical PCL's Return-on-Tangible-Equity compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Techno Medical PCL ranks #68 out of 113 companies for Return-on-Tangible-Equity. This places Techno Medical PCL in the lower half of its industry. The industry median Return-on-Tangible-Equity is 9.07. Techno Medical PCL's value of 7.51% is 17.2% below this benchmark. While the company's 10-year median is 8.12 vs. the industry median of 9.07, Techno Medical PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Medical Distribution company?
The median Return-on-Tangible-Equity among Medical Distribution companies is 9.07, based on 113 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medical PCL's current Return-on-Tangible-Equity of 7.51% is 17.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Techno Medical PCL and its competitors. For the Medical Distribution industry, the median Return-on-Tangible-Equity is 9.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medical PCL's current Return-on-Tangible-Equity is 7.51%, which is near median its own 10-year median of 8.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medical PCL stock overvalued right now?
Techno Medical PCL (BKK:TM-R) has a current Return-on-Tangible-Equity of 7.51%. The stock's GF Value™ is ฿3.03, compared to a current price of ฿2.32 — trading 23.4% below its estimated fair value. The current Return-on-Tangible-Equity is 7.51%, which is near median its 10-year median of 8.12 and 17.2% below the Medical Distribution industry median of 9.07. Techno Medical PCL's overall GF Score™ is 74/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Techno Medical PCL (BKK:TM-R), the current Return-on-Tangible-Equity is 7.51% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medical PCL (BKK:TM-R) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medical PCL stock appears to be undervalued.
The current stock price of ฿2.32 is trading 23.4% below its estimated GF Value™ of ฿3.03.
Key valuation signals for BKK:TM-R:
Return-on-Tangible-Equity: 7.51% (near median its 10-year median of 8.12)
GF Value™: ฿3.03 vs. price of ฿2.32 (23.4% below fair value)
Industry Position: 17.2% below the Medical Distribution median (#68 of 113)
No single metric tells the full story. See the BKK:TM-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medical PCL is a Thailand-based company engaged in the trading business of medical supplies, tools, and equipment. The business activity of the group is import and distribution of operating instruments and disposable supplies, central sterile supply department products, instrument and supply used in laboratory and blood bank, and equipment and tools for heart surgery. Its segments consist of Disposable Equipment and Supplies, Sales of Medical Equipment and Instruments and Services related to Nursing Care. Maximum of revenue is Sales of Disposable Equipment and Supplies.
74GF Score
Get the complete analysis for BKK:TM-R
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:TM-R has been successfully added to your 
